InVivo Therapeutics to Present at Canaccord Genuity’s Medical Technologies & Diagnostics Forum
November 06 2017 - 7:00AM
Business Wire
InVivo Therapeutics Holdings Corp. (NVIV) today
announced that Mark Perrin, Chief Executive Officer and Chairman,
will present at the upcoming Canaccord Genuity Medical Technologies
& Diagnostics Forum on Thursday, November 9, 2017 at 3:00 PM
Eastern Time at the Westin New York Grand Central Hotel in
Manhattan. Mr. Perrin will present an overview of the company’s
Neuro-Spinal Scaffold™ program and discuss other recent business
updates for the company during the presentation.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and
clinical-stage biomaterials and biotechnology company with a focus
on treatment of spinal cord injuries. The company was founded in
2005 with proprietary technology co-invented by Robert Langer,
Sc.D., Professor at Massachusetts Institute of Technology, and
Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital
and who now is affiliated with Massachusetts General Hospital. In
2011, the company earned the David S. Apple Award from the American
Spinal Injury Association for its outstanding contribution to
spinal cord injury medicine. In 2015, the company’s investigational
Neuro-Spinal Scaffold™ received the 2015 Becker’s Healthcare Spine
Device Award. The publicly-traded company is headquartered in
Cambridge, MA. For more details, visit
www.invivotherapeutics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171106005405/en/
InVivo Therapeutics Holdings Corp.Heather Hamel,
617-863-5530Investor RelationsInvestor-relations@invivotherapeutics.com
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Apr 2024 to May 2024
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From May 2023 to May 2024